Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.jmii.2020.12.010 http://scihub22266oqcxt.onion/10.1016/j.jmii.2020.12.010 33500211!7783458!33500211     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Microbiol+Immunol+Infect 2021 ; 54 (1): 37-45 Nephropedia Template TP {{tp|p=33500211|t=2021. Can hydroxychloroquine be protective against COVID-19-associated thrombotic events ?|pdf=|usr=}}{{33500211}} gab.com Text Can hydroxychloroquine be protective against COVID-19-associated thrombotic events JO: J Microbiol Immunol Infect http://www.kidney.de/pget.php?&tw=1&pmid=33500211 #FOAvip Although SARS-CoV-2 is considered a lung-tropic virus, severe COVID-19 is not just a viral pulmonary infection, clinically it is a multi-organ pathology with major coagulation abnormalities and thromboembolism events. Recently, antiphospholipid (aPL) antibodies were found increased in a large number of COVID-19 patients. Elevated aPL have been well documented in antiphospholipid syndrome (APS), a systemic autoimmune disorder characterized by recurrent venous or arterial thrombosis and/or obstetrical morbidity. Among treatment regimen of APS, hydroxychloroquine (HCQ) is one of the molecules proposed in the primary prevention of thrombosis and obstetrical morbidity in those patients. Due to its antithrombotic properties documented in APS therapy, HCQ could be considered a good candidate for the prevention of thrombotic events in COVID-19 patients in association with anticoagulant and its repurposing deserves further evaluation. Twit Text FOAVip Can hydroxychloroquine be protective against COVID-19-associated thrombotic events ????J Microbiol Immunol Infect http://www.kidney.de/pget.php?&tw=1&pmid=33500211 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33500211 #FOAvip English Wikipedia <ref>{{Cite pmid|33500211}}</ref> Can hydroxychloroquine be protective against COVID-19-associated thrombotic events ? #MMPMID33500211 Devaux CA; Camoin-Jau L; Mege JL; Raoult D J Microbiol Immunol Infect 2021[Feb]; 54 (1): 37-45 PMID33500211show ga Although SARS-CoV-2 is considered a lung-tropic virus, severe COVID-19 is not just a viral pulmonary infection, clinically it is a multi-organ pathology with major coagulation abnormalities and thromboembolism events. Recently, antiphospholipid (aPL) antibodies were found increased in a large number of COVID-19 patients. Elevated aPL have been well documented in antiphospholipid syndrome (APS), a systemic autoimmune disorder characterized by recurrent venous or arterial thrombosis and/or obstetrical morbidity. Among treatment regimen of APS, hydroxychloroquine (HCQ) is one of the molecules proposed in the primary prevention of thrombosis and obstetrical morbidity in those patients. Due to its antithrombotic properties documented in APS therapy, HCQ could be considered a good candidate for the prevention of thrombotic events in COVID-19 patients in association with anticoagulant and its repurposing deserves further evaluation. |*COVID-19 Drug Treatment[MESH] |Antibodies, Antiphospholipid/blood[MESH] |Antiphospholipid Syndrome/complications[MESH] |COVID-19/blood/virology[MESH] |Humans[MESH] |Hydroxychloroquine/*therapeutic use[MESH] |Morbidity[MESH] |SARS-CoV-2/isolation & purification[MESH]Can hydroxychloroquine be protective against COVID-19-associated throm(epmc).pdf DeepDyve Pubget Overpricing